Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
J Natl Cancer Inst
    June 2022

  1. Correction to: Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Jun 17. pii: 6609827. doi: 10.1093.
    >> Share

    April 2022
  2. LEHRER S, Rheinstein PH
    RE: Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Apr 23. pii: 6572816. doi: 10.1093.
    >> Share

  3. SCHRIJVER LH, Mooij TM, Pijpe A, Sonke GS, et al
    Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
    J Natl Cancer Inst. 2022;114:540-552.
    >> Share

    March 2022
  4. TUESLEY KM, Webb PM, Protani MM, Spilsbury K, et al
    Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Mar 9. pii: 6545294. doi: 10.1093.
    >> Share

    December 2021
  5. TAKAHASHI K
    Untangling the Relationship between Clonal Hematopoiesis and Ovarian Cancer Therapies.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486529. doi: 10.1093.
    >> Share

  6. WEBER-LASSALLE K, Ernst C, Reuss A, Mollenhoff K, et al
    Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients with Ovarian Cancer.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486427. doi: 10.1093.
    >> Share

    September 2021
  7. DE SOUZA C, Madden J, Koestler DC, Minn D, et al
    Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
    J Natl Cancer Inst. 2021;113:1246-1257.
    >> Share

    August 2021
  8. KURIAN AW, Abrahamse P, Bondarenko I, Hamilton AS, et al
    Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
    J Natl Cancer Inst. 2021 Aug 9. pii: 6346986. doi: 10.1093.
    >> Share

    July 2021
  9. CALLENS C, Vaur D, Soubeyran I, Rouleau E, et al
    Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
    J Natl Cancer Inst. 2021;113:917-923.
    >> Share

    March 2021
  10. WENZEL L, Osann K, McKinney C, Cella D, et al
    Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
    J Natl Cancer Inst. 2021 Mar 17. pii: 6174697. doi: 10.1093.
    >> Share

    November 2020
  11. PERES LC, Bethea TN, Camacho TF, Bandera EV, et al
    Racial differences in population attributable risk for epithelial ovarian cancer in the OCWAA Consortium.
    J Natl Cancer Inst. 2020 Nov 30. pii: 6012358. doi: 10.1093.
    >> Share

  12. SPAAN M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, et al
    Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology.
    J Natl Cancer Inst. 2020 Nov 17. pii: 5981708. doi: 10.1093.
    >> Share

    August 2020
  13. LEE AW, Rosenzweig S, Wiensch A, Ramus SJ, et al
    Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies.
    J Natl Cancer Inst. 2020 Aug 7. pii: 5885090. doi: 10.1093.
    >> Share

    May 2020
  14. KALACHAND RD, Stordal B, Madden S, Chandler B, et al
    BRCA1 promoter methylation and clinical outcomes in ovarian cancer: an individual patient data meta-analysis.
    J Natl Cancer Inst. 2020 May 15. pii: 5837681. doi: 10.1093.
    >> Share

    April 2020
  15. VOS JR, Ligtenberg MJL, Hoogerbrugge N
    Response to Tomao, Panici, and Tomao.
    J Natl Cancer Inst. 2020;112:425.
    >> Share

    February 2020
  16. YANG X, Song H, Leslie G, Engel C, et al
    Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D.
    J Natl Cancer Inst. 2020 Feb 28. pii: 5764125. doi: 10.1093.
    >> Share

    November 2019
  17. VERDOODT F, Dehlendorff C, Jaattela M, Strauss R, et al
    Antihistamines and ovarian cancer survival: nationwide cohort study and in vitro cell viability assay.
    J Natl Cancer Inst. 2019 Nov 5. pii: 5613208. doi: 10.1093.
    >> Share

    October 2019
  18. ZELEZNIK OA, Clish CB, Kraft P, Avila-Pancheco J, et al
    Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: a 23-year Prospective Study.
    J Natl Cancer Inst. 2019 Oct 8. pii: 5583767. doi: 10.1093.
    >> Share

    April 2019
  19. LI N, McInerny S, Zethoven M, Cheasley D, et al
    Combined tumor sequencing and case/control analyses of RAD51C in breast cancer.
    J Natl Cancer Inst. 2019 Apr 5. pii: 5428180. doi: 10.1093.
    >> Share

    November 2018
  20. TERRY MB, Daly MB, Phillips KA, Ma X, et al
    Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
    J Natl Cancer Inst. 2018 Nov 28. pii: 5212812. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016